Teknova to Report Second Quarter 2024 Financial Results on August 13, 2024
Alpha Teknova (Nasdaq: TKNO), a leading producer of critical reagents for novel therapies, vaccines, and molecular diagnostics, has announced its plans to report second quarter 2024 financial results on August 13, 2024, after market close. The company will host a webcast and conference call on the same day at 5:00 p.m. Eastern Time to discuss the results.
Investors and interested parties can access the live webcast through the Investor Relations section of Teknova's website or via a provided link. To participate in the call, registration is required to receive a unique PIN and dial-in information. A replay of the webcast will be available on the company's website approximately two hours after the event concludes.
Alpha Teknova (Nasdaq: TKNO), un produttore leader di reagenti critici per nuove terapie, vaccini e diagnostica molecolare, ha annunciato i suoi piani per riportare i risultati finanziari del secondo trimestre 2024 il 13 agosto 2024, dopo la chiusura del mercato. L'azienda ospiterà un webcast e una conferenza telefonica lo stesso giorno alle 17:00 ora orientale per discutere i risultati.
Investitori e parti interessate possono accedere al webcast in diretta tramite la sezione Relazioni con gli Investitori del sito web di Teknova o tramite un link fornito. Per partecipare alla chiamata, è necessaria la registrazione per ricevere un PIN unico e le informazioni per il dial-in. Una registrazione del webcast sarà disponibile sul sito web dell'azienda circa due ore dopo la conclusione dell'evento.
Alpha Teknova (Nasdaq: TKNO), un productor líder de reactivos críticos para nuevas terapias, vacunas y diagnósticos moleculares, ha anunciado sus planes para reportar los resultados financieros del segundo trimestre de 2024 el 13 de agosto de 2024, después del cierre del mercado. La compañía realizará un webcast y una conferencia telefónica el mismo día a las 5:00 p.m. hora del este para discutir los resultados.
Los inversores y partes interesadas pueden acceder al webcast en vivo a través de la sección de Relaciones con Inversores del sitio web de Teknova o a través de un enlace proporcionado. Para participar en la llamada, es necesaria la registración para recibir un PIN único y la información de acceso. Una repetición del webcast estará disponible en el sitio web de la empresa aproximadamente dos horas después de que concluye el evento.
알파 테크노바(나스닥: TKNO), 새로운 치료법, 백신 및 분자 진단을 위한 중요한 시약의 선도적인 생산자가 2024년 2분기 재무 결과를 2024년 8월 13일, 시장 마감 후 발표할 계획을 발표했습니다. 회사는 같은 날 동부 표준시 기준 오후 5:00에 결과를 논의하기 위한 웹캐스트 및 전화 회의를 개최할 예정입니다.
투자자 및 관심 있는 당사자는 테크노바 웹사이트의 투자자 관계 섹션 또는 제공된 링크를 통해 실시간 웹캐스트에 접근할 수 있습니다. 통화에 참여하려면 고유 PIN과 전화 접속 정보를 받기 위해 등록이 필요합니다. 웹캐스트의 재생은 이벤트 종료 후 약 2시간 후에 회사 웹사이트에서 제공됩니다.
Alpha Teknova (Nasdaq: TKNO), un producteur leader de réactifs critiques pour de nouvelles thérapies, des vaccins et des diagnostics moléculaires, a annoncé ses projets de communiquer les résultats financiers du deuxième trimestre 2024 le 13 août 2024, après la fermeture du marché. L'entreprise organisera un webinaire et une conférence téléphonique le même jour à 17h00, heure de l'Est, pour discuter des résultats.
Les investisseurs et parties intéressées peuvent accéder au webinaire en direct via la section Relations Investisseurs du site Web de Teknova ou via un lien fourni. Pour participer à l'appel, une inscription est nécessaire pour recevoir un code PIN unique et des informations de connexion. Un enregistrement du webinaire sera disponible sur le site Web de l'entreprise environ deux heures après la conclusion de l'événement.
Alpha Teknova (Nasdaq: TKNO), ein führender Hersteller von kritischen Reagenzien für neuartige Therapien, Impfstoffe und molekulare Diagnostik, hat seine Pläne angekündigt, die Finanzergebnisse für das zweite Quartal 2024 am 13. August 2024, nach Marktschluss, bekannt zu geben. Das Unternehmen wird am selben Tag um 17:00 Uhr Eastern Time ein Webcast und eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen.
Investoren und interessierte Parteien können über den Bereich Investor Relations auf der Teknova-Website oder über einen bereitgestellten Link auf das Live-Webcast zugreifen. Um an dem Anruf teilzunehmen, ist eine Registrierung erforderlich, um eine eindeutige PIN und Einwahlinformationen zu erhalten. Eine Aufzeichnung des Webcasts wird etwa zwei Stunden nach Ende der Veranstaltung auf der Website des Unternehmens verfügbar sein.
- None.
- None.
HOLLISTER, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the second quarter ended June 30, 2024, on Tuesday, August 13, 2024, following the close of market.
Teknova will host a webcast and conference call on Tuesday, August 13, 2024, beginning at 5:00 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the Investor Relations section of the Teknova website or by using this link. If you would like to participate in the call, please register for the webcast here to receive a unique PIN number and dial-in information. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Teknova
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel therapies that will help people live longer, healthier lives. Teknova offers fully customizable solutions for every stage of the workflow, supporting industry leaders in cell and gene therapy, molecular diagnostics, and synthetic biology. The Company’s fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps their customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 200,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by its team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of novel therapies.
Investor Contact
Matt Lowell
Chief Financial Officer
matt.lowell@teknova.com
+1 831-637-1100
Media Contact
Jennifer Henry
Senior Vice President, Marketing
jenn.henry@teknova.com
+1 831-313-1259
FAQ
When will Teknova (TKNO) report its Q2 2024 financial results?
What time is Teknova's (TKNO) Q2 2024 earnings call scheduled for?
How can investors access Teknova's (TKNO) Q2 2024 earnings webcast?
Will there be a replay available for Teknova's (TKNO) Q2 2024 earnings call?
